Avextra AG

European pharmaceutical cannabis-based medicines provider Avextra AG has closed its most recent capital raise with support from existing investors, strategic partners and new institutional investors. What Happened The German company said on Wednesday, that it has raised more than EUR20 million ($21...

European vertically-integrated manufacturer of cannabis-based medicines Avextra AG unveiled the Avextra Alliance for Evidence-based Cannabis Medicine on Wednesday The alliance is an initiative to advance research and development in cannabinoid-based therapies in European markets where...

Avextra AG, a vertically-integrated manufacturer of cannabis-based medicines located in Germany, announced the export of its standardised cannabis extracts to Italy. Italy is a key market for Avextra, with the second-largest patient population for cannabis-based medicines in the European Union....

Avextra AG has announced the closing of a capital raise worth EU 17 Million (via a convertible loan note) supported by its current investors, entire management team, and additional investors from across Europe. "We are very proud of the confidence investors have shown us. We will...